Skip to main content

Protalix BioTherapeutics, Inc.

PLX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001006281

No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Protalix BioTherapeutics, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of PLX: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders6166+5
Shares9.17M9.86M+696.8K (+7.6%)
Value$15.2M$17.6M+$2.35M (+15.4%)

New holders (12)

Institutions that held Protalix BioTherapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to PLX in Q4 2023
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP103,250$183.8K0.00%
Bailard, Inc.68,100$121.2K0.00%
Two Sigma Securities, LLC44,474$79.2K0.00%
Franklin Resources Inc33,548$59.7K0.00%
Jane Street Group, LLC28,825$51.3K0.00%
State Board of Administration of Florida Retirement System17,228$30.7K0.00%
Finivi Inc.14,544$25.9K0.03%
ProShare Advisors LLC10,979$19.5K0.00%
Manufacturers Life Insurance Company, The10,514$18.7K0.00%
Natixis5,000$8.90K0.00%
Advisory Services Network, LLC100$1780.00%
The PNC Financial Services Group, Inc.19$340.00%

Sold out (7)

Institutions that held Protalix BioTherapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of PLX in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Allspring Global Investments Holdings, LLC137,906$228.9K
State of Wyoming41,268$68.5K
Citadel Advisors LLC25,614$42.5K
Virtu Financial LLC11,184$19.0K
Simplex Trading, LLC4,813$7.00K
Russell Investments Group, Ltd.2,764$4.59K
Geneos Wealth Management Inc.2,000$3.32K